tiprankstipranks
Trending News
More News >
Stimcell Energetics, Inc. (STME)
:STME
US Market

Stimcell Energetics (STME) Price & Analysis

Compare
22 Followers

STME Stock Chart & Stats


Options Prices

Currently, No data available
---

Ownership Overview

29.38%70.62%
29.38% Insiders
― Other Institutional Investors
70.62% Public Companies and
Individual Investors

STME FAQ

What was Stimcell Energetics, Inc.’s price range in the past 12 months?
Stimcell Energetics, Inc. lowest stock price was <$0.01 and its highest was $0.60 in the past 12 months.
    What is Stimcell Energetics, Inc.’s market cap?
    Stimcell Energetics, Inc.’s market cap is $7.17M.
      When is Stimcell Energetics, Inc.’s upcoming earnings report date?
      The company’s upcoming earnings report date is not yet available.
      How were Stimcell Energetics, Inc.’s earnings last quarter?
      Currently, no data Available
      Is Stimcell Energetics, Inc. overvalued?
      According to Wall Street analysts Stimcell Energetics, Inc.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Stimcell Energetics, Inc. pay dividends?
        Stimcell Energetics, Inc. does not currently pay dividends.
        What is Stimcell Energetics, Inc.’s EPS estimate?
        Stimcell Energetics, Inc.’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does Stimcell Energetics, Inc. have?
        Stimcell Energetics, Inc. has 19,816,273 shares outstanding.
          What happened to Stimcell Energetics, Inc.’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of Stimcell Energetics, Inc.?
          Currently, no hedge funds are holding shares in STME

          Company Description

          Stimcell Energetics, Inc.

          Cell MedX Corp. is a development stage company, which engages in the discovery, development and commercialization of therapeutic and non-therapeutic products that promote general wellness. Its products include electromedical technology, and ebalance technology for diabetes and related complications The company was founded on March 19, 2010 and is headquartered in Carson City, NV.
          Similar Stocks
          Company
          Price & Change
          Follow
          Immuron
          Bioxcel Therapeutics
          Hookipa Pharma
          Athira Pharma
          bioAffinity Technologies, Inc.
          Popular Stocks
          What am I Missing?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis